FI101597B1 - Menetelmä kylmäkuivatun koostumuksen valmistamiseksi käytettäväksi potilaan valodynaamisessa hoidossa tai diagnosoinnissa - Google Patents

Menetelmä kylmäkuivatun koostumuksen valmistamiseksi käytettäväksi potilaan valodynaamisessa hoidossa tai diagnosoinnissa

Info

Publication number: FI101597B1
Authority: FI; Finland
Prior art keywords: preparing; photodynamic therapy; diagnosis; patient; lyophilized composition
Prior art date: 1989-06-14

Application number

FI902966A

Other languages

English (en)

Swedish (sv)

Other versions

FI101597B (fi

FI902966A0 (fi

Inventor

Bruce E Haeger

James R Lawter

Vijay H Naringrekar

Michael C Cucolo

Original Assignee

Quadra Logic Tech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-06-14

Filing date

1990-06-13

Publication date

1998-07-31

1990-06-13 Application filed by Quadra Logic Tech Inc filed Critical Quadra Logic Tech Inc

1990-06-13 Publication of FI902966A0 publication Critical patent/FI902966A0/fi

1998-07-31 Application granted granted Critical

1998-07-31 Publication of FI101597B publication Critical patent/FI101597B/fi

1998-07-31 Publication of FI101597B1 publication Critical patent/FI101597B1/fi

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Investigating Or Analysing Biological Materials (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

FI902966A 1989-06-14 1990-06-13 Menetelmä kylmäkuivatun koostumuksen valmistamiseksi käytettäväksi potilaan valodynaamisessa hoidossa tai diagnosoinnissa FI101597B1 (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US07/366,374 US5059619A (en)	1989-06-14	1989-06-14	Stable freeze-dried polyhematoporphyrin ether/ester
US36637489		1989-06-14

Publications (3)

Publication Number	Publication Date
FI902966A0 FI902966A0 (fi)	1990-06-13
FI101597B FI101597B (fi)	1998-07-31
FI101597B1 true FI101597B1 (fi)	1998-07-31

Family

ID=23442747

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI902966A FI101597B1 (fi)	1989-06-14	1990-06-13	Menetelmä kylmäkuivatun koostumuksen valmistamiseksi käytettäväksi potilaan valodynaamisessa hoidossa tai diagnosoinnissa

Country Status (26)

Country	Link
US (1)	US5059619A (fi)
EP (1)	EP0402637B1 (fi)
JP (1)	JP3112918B2 (fi)
KR (1)	KR0164845B1 (fi)
CN (1)	CN1058388C (fi)
AR (1)	AR244549A1 (fi)
AT (1)	ATE144703T1 (fi)
AU (1)	AU625549B2 (fi)
CA (1)	CA2018751C (fi)
CZ (1)	CZ283309B6 (fi)
DD (1)	DD295087A5 (fi)
DE (1)	DE69029012T2 (fi)
DK (1)	DK0402637T3 (fi)
ES (1)	ES2095846T3 (fi)
FI (1)	FI101597B1 (fi)
GR (1)	GR3021511T3 (fi)
HU (1)	HU215522B (fi)
IE (1)	IE902137A1 (fi)
IL (1)	IL94448A (fi)
NO (1)	NO176645C (fi)
NZ (1)	NZ233953A (fi)
PL (1)	PL164744B1 (fi)
PT (1)	PT94344B (fi)
RU (1)	RU2019990C1 (fi)
TW (1)	TW225475B (fi)
ZA (1)	ZA904599B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6187572B1 (en)	1990-04-16	2001-02-13	Baxter International Inc.	Method of inactivation of viral and bacterial blood contaminants
US5418130A (en)	1990-04-16	1995-05-23	Cryopharm Corporation	Method of inactivation of viral and bacterial blood contaminants
US5244914A (en) *	1992-04-27	1993-09-14	American Cyanamid Company	Stable porfimer sodium compositions and methods for their manufacture
NO180167C (no) *	1994-09-08	1997-02-26	Photocure As	Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
US5660181A (en) *	1994-12-12	1997-08-26	Physical Optics Corporation	Hybrid neural network and multiple fiber probe for in-depth 3-D mapping
GB9512854D0 (en) *	1995-06-23	1995-08-23	Wellcome Found	Novel formulation
US5958104A (en) *	1997-09-11	1999-09-28	Nonomura; Arthur M.	Methods and compositions for enhancing plant growth
CA2221912A1 (en) *	1997-11-21	1999-05-21	David Dolphin	Photosensitizers with improved biodistribution and light-absorbing properties
KR20080080685A (ko)	2000-11-29	2008-09-04	피씨아이 바이오테크 에이에스	사이토졸 내로의 분자 전달을 위한 광화학적 내부이행
JP4638654B2 (ja)	2000-11-29	2011-02-23	ピーシーアイバイオテックエイエス	ウィルス媒介の細胞質中への分子送達のための光化学的内在化
US7175611B2 (en)	2002-06-05	2007-02-13	Mark Alan Mitchnick	Antimicrobial release system
CN103961323B (zh) *	2013-02-05	2017-10-17	浙江海正药业股份有限公司	一种注射用hpph冻干粉针制剂及其制备方法
US9733187B2 (en) *	2015-03-06	2017-08-15	King Saud University	Method of detecting bladder cancer by optical analysis of bodily fluids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2858320A (en) *	1956-04-02	1958-10-28	Baxter Laboratories Inc	Stable hematoporphyrin
US4649151A (en) *	1982-09-27	1987-03-10	Health Research, Inc.	Drugs comprising porphyrins
US4753958A (en) *	1985-02-07	1988-06-28	University Of Cal	Photochemotherapy of epithelial diseases with derivatives of hematoporphyrins
CA1291710C (en) *	1985-04-30	1991-11-05	Jerry C. Bommer	Tetrapyrrole therapeutic agents
US4882234A (en) *	1986-11-12	1989-11-21	Healux, Inc.	Storage-stable porphin compositions and a method for their manufacture
US4968715A (en) *	1988-07-06	1990-11-06	Health Research, Inc.	Use of purified hematoporphyrin trimers in photodynamic therapy

1989
- 1989-06-14 US US07/366,374 patent/US5059619A/en not_active Expired - Lifetime
1990
- 1990-05-14 EP EP90109031A patent/EP0402637B1/en not_active Expired - Lifetime
- 1990-05-14 DK DK90109031.6T patent/DK0402637T3/da active
- 1990-05-14 ES ES90109031T patent/ES2095846T3/es not_active Expired - Lifetime
- 1990-05-14 DE DE69029012T patent/DE69029012T2/de not_active Expired - Lifetime
- 1990-05-14 AT AT90109031T patent/ATE144703T1/de not_active IP Right Cessation
- 1990-05-17 TW TW079103997A patent/TW225475B/zh active
- 1990-05-20 IL IL9444890A patent/IL94448A/en not_active IP Right Cessation
- 1990-06-05 CN CN90104366A patent/CN1058388C/zh not_active Expired - Lifetime
- 1990-06-06 NZ NZ233953A patent/NZ233953A/en unknown
- 1990-06-11 CZ CS902889A patent/CZ283309B6/cs not_active IP Right Cessation
- 1990-06-11 JP JP02150078A patent/JP3112918B2/ja not_active Expired - Lifetime
- 1990-06-12 CA CA002018751A patent/CA2018751C/en not_active Expired - Lifetime
- 1990-06-12 PT PT94344A patent/PT94344B/pt not_active IP Right Cessation
- 1990-06-13 NO NO902634A patent/NO176645C/no not_active IP Right Cessation
- 1990-06-13 AU AU57089/90A patent/AU625549B2/en not_active Expired
- 1990-06-13 ZA ZA904599A patent/ZA904599B/xx unknown
- 1990-06-13 AR AR90317109A patent/AR244549A1/es active
- 1990-06-13 RU SU904830142A patent/RU2019990C1/ru active
- 1990-06-13 PL PL90285633A patent/PL164744B1/pl unknown
- 1990-06-13 IE IE213790A patent/IE902137A1/en not_active IP Right Cessation
- 1990-06-13 KR KR1019900008676A patent/KR0164845B1/ko not_active IP Right Cessation
- 1990-06-13 FI FI902966A patent/FI101597B1/fi active IP Right Grant
- 1990-06-14 HU HU903850A patent/HU215522B/hu unknown
- 1990-06-14 DD DD90341641A patent/DD295087A5/de unknown
1996
- 1996-10-31 GR GR960402151T patent/GR3021511T3/el unknown

Also Published As

Publication number	Publication date
KR0164845B1 (ko)	1999-01-15
HUT54888A (en)	1991-04-29
KR910000146A (ko)	1991-01-29
NO902634L (no)	1990-12-17
IE902137L (en)	1990-12-14
CA2018751A1 (en)	1990-12-14
FI101597B (fi)	1998-07-31
PT94344A (pt)	1991-02-08
ES2095846T3 (es)	1997-03-01
DE69029012T2 (de)	1997-02-27
HU903850D0 (en)	1990-11-28
CN1058388C (zh)	2000-11-15
CS9002889A2 (en)	1991-11-12
EP0402637B1 (en)	1996-10-30
NO176645C (no)	1995-05-10
IL94448A (en)	1994-06-24
JP3112918B2 (ja)	2000-11-27
DK0402637T3 (da)	1997-04-07
FI902966A0 (fi)	1990-06-13
AU5708990A (en)	1990-12-20
TW225475B (fi)	1994-06-21
EP0402637A2 (en)	1990-12-19
NO176645B (no)	1995-01-30
HU215522B (hu)	1999-01-28
AU625549B2 (en)	1992-07-16
PT94344B (pt)	1997-04-30
AR244549A1 (es)	1993-11-30
PL164744B1 (pl)	1994-10-31
IE902137A1 (en)	1991-01-02
NO902634D0 (no)	1990-06-13
CA2018751C (en)	2001-08-21
CZ283309B6 (cs)	1998-02-18
DD295087A5 (de)	1991-10-24
GR3021511T3 (en)	1997-01-31
ZA904599B (en)	1991-04-24
JPH0331283A (ja)	1991-02-12
EP0402637A3 (en)	1991-04-03
NZ233953A (en)	1992-08-26
IL94448A0 (en)	1991-03-10
DE69029012D1 (de)	1996-12-05
CN1047973A (zh)	1990-12-26
ATE144703T1 (de)	1996-11-15
RU2019990C1 (ru)	1994-09-30
US5059619A (en)	1991-10-22

Publication	Publication Date	Title
FI922151A (fi)	1992-05-12	Metall-peptidkompositioner och metoder foer stimulering av haortillvaext.
ATE92930T1 (de)	1993-08-15	Saponinkomplexe mit phospholipiden und sie enthaltende pharmazeutische und kosmetische zusammensetzungen.
LU91498I2 (fr)	2009-01-19	Etanercept et ses dérivés pharmaceutiquement acceptables.
AU1808488A (en)	1988-12-06	Compounds for the treatment of alzheimer's disease
FI101597B1 (fi)	1998-07-31	Menetelmä kylmäkuivatun koostumuksen valmistamiseksi käytettäväksi potilaan valodynaamisessa hoidossa tai diagnosoinnissa
SG48298A1 (en)	1998-04-17	Saccharin deriatives useful as proteolytic enzymeinhibitors and preparation of
ES2157886T3 (es)	2001-09-01	Composiciones tensioactivas y procedimientos.
FI895141A0 (fi)	1989-10-30	Kelatmedel med orto-ligerande funktionalitet och deras komplexer.
AU536582B2 (en)	1984-05-10	Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
DE3462688D1 (en)	1987-04-23	1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
EP0342617A3 (en)	1990-04-04	Use of pyrimido-(6,1-a)isoquinolin-4-one derivatives, and medical preparations based on same
GR3005231T3 (fi)	1993-05-24
DE3473826D1 (en)	1988-10-13	N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor
IL98200A0 (en)	1992-06-21	Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
SE8400118L (sv)	1984-07-13	Substituerade karboxi-tiazolo/3,2-a/pyrimidinderivat och forfarande for deras framstellning
ATE70440T1 (de)	1992-01-15	Verwendung von anipamil als artereosklerosemittel.
ATE96035T1 (de)	1993-11-15	Verwendung eines polypeptides mit gammainterferon-aktivitaet zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von primitivem pleura-krebs.
IT1248485B (it)	1995-01-19	Derivati della 1,4-benzotiazina ad azione immunostimolante e immonomodulatrice

Legal Events

Date	Code	Title	Description
2003-11-02	SPCL	Withdrawal, rejection or dismissal of a supplementary protection certificate	Spc suppl protection certif: L19990012
2004-08-31	FG	Patent granted	Owner name: AXCAN PHARMA (IRELAND) LIMITED
2004-09-24	PC	Transfer of assignment of patent	Owner name: AXCAN PHARMA (IRELAND) LIMITED